Paediatric
Influenza prophylaxis
- Usually following advice from Micro/ID team or Infection Prevention and Control nurse.
- All use must be as per UKHSA guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza, i.e.
- National surveillance schemes have indicated that influenza virus is circulating AND;
- The person has been exposed to an index case (close contact in a hospital, household or residential setting) AND;
- Able to begin prophylaxis within 48hours AND;
- Patient is at risk of severe complicated influenza
For neonatal exposure, discuss with Paeds ID.
Preferred
Oseltamivir po, see dosing table, for 10 days
|
Age |
Oseltamivir prophylaxis dose |
|
Infants under 12 months (36 weeks post conceptional age or greater) |
3mg/kg OD (max. per dose 30mg) |
|
1–12 years (less than or equal to 15kg) |
30mg OD |
|
1–12 years (more than 15kg to 23kg) |
45mg OD |
|
1–12 years (more than 23kg to 40kg) |
60mg OD |
|
1–12 years (more than 40kg) |
75mg OD |
|
13 years and over (upto 40kg) |
60mg OD |
|
13 years and over (more that 40kg) |
75mg OD |
Dosing in Renal impairment: Discuss with pharmacist
If the patient is unable to have oseltamivir: Discuss with Paeds ID